Caregiver

PenFed Credit Union and San Diego Wave FC Partner for Military Appreciation Night

Retrieved on: 
Saturday, May 27, 2023

TYSONS, Va., May 27, 2023 /PRNewswire/ -- PenFed Credit Union, the nation's second-largest federal credit union, served as the presenting partner of the San Diego Wave's Military Appreciation Night on Friday, May 26, at Snapdragon Stadium vs. the Portland Thorns. The night featured numerous military activations, including inviting 1,000 military members and their families to attend the match.

Key Points: 
  • The May 26 Game vs. Portland Thorns Honored Active and Retired Service Members
    TYSONS, Va., May 27, 2023 /PRNewswire/ -- PenFed Credit Union , the nation's second-largest federal credit union, served as the presenting partner of the San Diego Wave's Military Appreciation Night on Friday, May 26, at Snapdragon Stadium vs. the Portland Thorns.
  • The night featured numerous military activations, including inviting 1,000 military members and their families to attend the match.
  • "PenFed is proud to support the national military and defense community every day since our founding over 88 years ago," said PenFed President/CEO James Schenck.
  • "It was an honor to partner with the Wave to show appreciation for the many veterans and active-duty service members and their families in the San Diego region."

Senior Care Franchise Right at Home Targets Baton Rouge Expansion, Looking to Meet with Qualified Prospective Franchisees Wanting to Make a Difference in Their Community

Retrieved on: 
Saturday, May 27, 2023

BATON ROUGE, La., May 27, 2023 /PRNewswire-PRWeb/ -- Right at Home, the 700-plus location in-home care concept helping seniors and adults with disabilities live comfortably at home, is looking to expand in Baton Rouge, Louisiana. The opportunity gives local entrepreneurs a chance to make a difference in their communities and provide peace of mind to families needing care.

Key Points: 
  • BATON ROUGE, La., May 27, 2023 /PRNewswire-PRWeb/ -- Right at Home, the 700-plus location in-home care concept helping seniors and adults with disabilities live comfortably at home, is looking to expand in Baton Rouge, Louisiana.
  • The opportunity gives local entrepreneurs a chance to make a difference in their communities and provide peace of mind to families needing care.
  • With persons aged 65 and over making up 14.2% of the population, Baton Rouge is primed for Right at Home's services.
  • This year, Right at Home is looking forward to building on that growth, including in Baton Rouge.

SEIU: Healthcare Workers Vote to Strike Across LifeLong Medical Care Clinics Over Silencing Workers, Bargaining in Bad Faith

Retrieved on: 
Friday, May 26, 2023

OAKLAND, Calif., May 26, 2023 /PRNewswire/ -- Healthcare workers at LifeLong Medical Clinics have overwhelmingly voted to go on strike over management's attempts to silence them for trying to solve staffing and patient care problems, and to demand management bargain in good faith for solutions.

Key Points: 
  • "We are ready to strike because management refuses to listen to healthcare workers and is not bargaining with us in good faith," said Mable Bermudez-Chun, a community health worker at LifeLong Brookside Clinic.
  • Workers at Lifelong Medical Care are concerned about worker safety and threats to the quality of patient care due to understaffing.
  • The strike vote applies to more than 500 healthcare workers in a variety of job classes, including registered nurses, medical assistants, social workers, dental assistants, community health workers, street medicine workers, patient care representatives, and others.
  • SEIU-United Healthcare Workers West (SEIU-UHW) is a healthcare justice union of more than 100,000 healthcare workers, patients, and healthcare activists united to ensure affordable, accessible, high-quality care for all Californians, provided by valued and respected healthcare workers.

PenFed Credit Union Dedicates Concourse C Connector at Washington Dulles International Airport to Fallen Military Heroes for Memorial Day Weekend

Retrieved on: 
Friday, May 26, 2023

TYSONS, Va., May 26, 2023 /PRNewswire/ -- PenFed Credit Union, the nation's second largest federal credit union, will dedicate the PenFed Tunnel in the Concourse C Connector at Washington Dulles International Airport (IAD) to our nation's military heroes who made the ultimate sacrifice during Memorial Day weekend.  The millions of air travelers who make their way through the PenFed Tunnel will be reminded of our fallen heroes' sacrifices with images and videos depicting the importance of honoring, reflecting and supporting.

Key Points: 
  • TYSONS, Va., May 26, 2023 /PRNewswire/ -- PenFed Credit Union , the nation's second largest federal credit union, will dedicate the PenFed Tunnel in the Concourse C Connector at Washington Dulles International Airport (IAD) to our nation's military heroes who made the ultimate sacrifice during Memorial Day weekend.
  • The millions of air travelers who make their way through the PenFed Tunnel will be reminded of our fallen heroes' sacrifices with images and videos depicting the importance of honoring, reflecting and supporting.
  • "At PenFed, we believe it's important to always remember the brave men and women who gave their lives for our nation, and the loved ones they left behind," said PenFed Credit Union President/CEO and PenFed Foundation CEO James Schenck.
  • "This Memorial Day weekend, the PenFed Tunnel will provide a unique way to honor those who lost their lives to keep us safe and ensure our freedoms.

BioXcel Therapeutics Announces Promising Topline Results from Part 1 of Pivotal SERENITY III Trial of BXCL501 for At-Home Use in Acute Treatment of Agitation in Bipolar Disorders or Schizophrenia

Retrieved on: 
Thursday, May 25, 2023

BXCL501 would represent the first-ever FDA approved therapy for at-home use in this indication, if approved.

Key Points: 
  • BXCL501 would represent the first-ever FDA approved therapy for at-home use in this indication, if approved.
  • SERENITY III is a two-part, double-blinded, placebo-controlled pivotal study designed to evaluate BXCL501 in acutely agitated adult patients with bipolar disorders or schizophrenia for at-home use.
  • Although the primary efficacy endpoint was not statistically significant at 2 hours (p=0.077), BXCL501 separated from placebo at 4 hours (p=0.049).
  • These data provide a clear path for initiating SERENITY III Part 2, to pursue approval in the at-home setting.

Apellis Reports Top-Line Results from Phase 2 MERIDIAN Study in ALS

Retrieved on: 
Thursday, May 25, 2023

Systemic pegcetacoplan was well tolerated in the study, and the data were consistent with the established safety profile.

Key Points: 
  • Systemic pegcetacoplan was well tolerated in the study, and the data were consistent with the established safety profile.
  • Based on the lack of efficacy, Apellis and Sobi plan to discontinue development of systemic pegcetacoplan for ALS.
  • In April, Apellis and Sobi discontinued treatment in the open-label portion of the study, following a recommendation from an independent data monitoring committee.
  • “We are disappointed in the outcome of the MERIDIAN study, especially on behalf of the ALS community who has been waiting for new treatments for this complex and unrelenting disease.

Annexon Topline Data from ARCHER Phase 2 Trial of ANX007 in Geographic Atrophy Demonstrated Statistically Significant, Dose-Dependent Preservation of Visual Function

Retrieved on: 
Wednesday, May 24, 2023

Patients in the pooled treatment group showed a 59% reduction in risk of >15-letter loss (n=181, p=0.008).

Key Points: 
  • Patients in the pooled treatment group showed a 59% reduction in risk of >15-letter loss (n=181, p=0.008).
  • The primary endpoint of mean rate of change (slope) in GA lesion area compared to sham at 12 months did not reach statistical significance.
  • The totality of the data on ANX007 from the ARCHER trial are promising, with the demonstrated preservation of functional vision in GA patients, regardless of their lesion location or size.
  • Preclinical models have demonstrated that inhibition of C1q protects photoreceptor cell synapses, and importantly, photoreceptor cell function.

Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference

Retrieved on: 
Tuesday, May 23, 2023

In line with previous guidance, Mereo is continuing to explore potential partnerships to fund the Phase 3 development of alvelestat.

Key Points: 
  • In line with previous guidance, Mereo is continuing to explore potential partnerships to fund the Phase 3 development of alvelestat.
  • Headache is a known adverse event associated with alvelestat and is being addressed through dose-escalation during initiation of alvelestat treatment.
  • The secondary endpoints were the proportion of patients with NE below the limit of quantitation and PK, safety and tolerability.
  • Exploratory endpoints included rate of acute exacerbations of COPD, pulmonary function tests, St George’s Respiratory Questionnaire, inflammatory and lung damage biomarkers.

Global Ambient Assisted Living and Smart Home Market Report 2023: Sector is Expected to Reach $645.19 Billion by 2030 at a CAGR of 29.7% - ResearchAndMarkets.com

Retrieved on: 
Friday, May 26, 2023

With the rise of digital assistants like Alexa, Google Assistant, Siri, and Bixby, smart home devices can be operated and controlled using voice commands.

Key Points: 
  • With the rise of digital assistants like Alexa, Google Assistant, Siri, and Bixby, smart home devices can be operated and controlled using voice commands.
  • These virtual assistants' offer features, such as control Bluetooth connectivity and hands-free channel browsing are driving the market growth.
  • Based on the ambient assisted living type, the safety & security segment held the largest revenue share of 20.9% in 2022.
  • The compensatory impairment segment is expected to witness the highest CAGR rate of 30.9% during the forecast period.

Modivcare Releases 2022 Environmental, Social, and Governance Report Highlighting Commitment to Eliminating Inequities in Healthcare and Enhancing Sustainability Efforts

Retrieved on: 
Thursday, May 25, 2023

The annual report provides an update regarding Modivcare’s ESG governance and sustainability efforts, as well as progress made to eliminate inequities in healthcare through its supportive care services focused on the social determinants of health.

Key Points: 
  • The annual report provides an update regarding Modivcare’s ESG governance and sustainability efforts, as well as progress made to eliminate inequities in healthcare through its supportive care services focused on the social determinants of health.
  • “Our annual ESG report illustrates our commitment to provide greater access to healthcare for the country’s most vulnerable populations,” said L. Heath Sampson, President and Chief Executive Officer of Modivcare.
  • We remain committed to enhancing our sustainability and reducing our greenhouse gas emissions, as our ESG report shows a 15% year-over-year reduction in our Scope 1 emissions.
  • Philanthropy and Community Engagement: Our community engagement initiatives are focused on the social determinants of health and eliminating inequities in healthcare.